Fate therapeutics to webcast conference call reporting second quarter 2021 financial results

San diego, july 15, 2021 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced that the company will host a conference call and live audio webcast on wednesday, august 4, 2021 at 5:00 p.m. et to report its second quarter 2021 financial results and provide a corporate update.
FATE Ratings Summary
FATE Quant Ranking